Segall Bryant & Hamill’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.9M Sell
253,885
-62,626
-20% -$5.62M 0.31% 101
2025
Q4
$27.6M Sell
316,511
-165,125
-34% -$12.5M 0.37% 81
2025
Q3
$27.6M Buy
481,636
+13,583
+3% +$782K 0.37% 85
2025
Q2
$27.6M Buy
468,053
+29,539
+7% +$1.91M 0.39% 76
2025
Q1
$32.1M Buy
438,514
+36,656
+9% +$3.03M 0.49% 50
2024
Q4
$33.2M Buy
401,858
+14,121
+4% +$1.11M 0.46% 60
2024
Q3
$27.7M Buy
387,737
+26,047
+7% +$1.84M 0.38% 83
2024
Q2
$24.8M Buy
361,690
+40,906
+13% +$2.44M 0.44% 73
2024
Q1
$17.2M Buy
320,784
+90
+0% +$4.84K 0.32% 106
2023
Q4
$17.1M Buy
320,694
+18,182
+6% +$886K 0.33% 106
2023
Q3
$15M Sell
302,512
-41,504
-12% -$2.32M 0.17% 152
2023
Q2
$20.5M Buy
344,016
+3,254
+1% +$185K 0.21% 129
2023
Q1
$19.3M Sell
340,762
-2
-0% -$128 0.21% 135
2022
Q4
$25.3M Sell
340,764
-71,011
-17% -$4.84M 0.28% 108
2022
Q3
$24.5M Buy
411,775
+53,729
+15% +$3.24M 0.29% 102
2022
Q2
$20.1M Buy
358,046
+62,462
+21% +$4.11M 0.23% 123
2022
Q1
$21.8M Buy
295,584
+924
+0.3% +$64.2K 0.21% 130
2021
Q4
$21.3M Buy
294,660
+26,346
+10% +$1.91M 0.2% 134
2021
Q3
$20.6M Buy
268,314
+4,980
+2% +$400K 0.2% 129
2021
Q2
$20.4M Buy
263,334
+18,569
+8% +$1.32M 0.2% 134
2021
Q1
$15.1M Sell
244,765
-35,222
-13% -$2.23M 0.15% 165
2020
Q4
$18.3M Buy
279,987
+7,485
+3% +$430K 0.2% 130
2020
Q3
$13.5M Buy
272,502
+117,555
+76% +$6.06M 0.18% 130
2020
Q2
$7.39M Sell
154,947
-15,760
-9% -$760K 0.12% 170
2020
Q1
$7.26M Buy
170,707
+31,945
+23% +$1.58M 0.15% 141
2019
Q4
$8.17M Sell
138,762
-22,435
-14% -$1.22M 0.13% 167
2019
Q3
$8.24M Sell
161,197
-6,497
-4% -$309K 0.13% 199
2019
Q2
$7.09M Buy
167,694
+18,248
+12% +$792K 0.11% 221
2019
Q1
$7.38M Sell
149,446
-13,228
-8% -$598K 0.11% 218
2018
Q4
$7.04M Sell
162,674
-3,970
-2% -$198K 0.12% 213
2018
Q3
$9.46M Sell
166,644
-8,098
-5% -$426K 0.14% 196
2018
Q2
$8.82M Sell
174,742
-67,297
-28% -$3.51M 0.13% 208
2018
Q1
$12.1M Sell
242,039
-95,930
-28% -$4.51M 0.28% 94
2017
Q4
$13.9M Buy
337,969
+18,315
+6% +$641K 0.31% 91
2017
Q3
$9.5M Sell
319,654
-4,993
-2% -$152K 0.22% 111
2017
Q2
$10.8M Sell
324,647
-3,005
-0.9% -$94.4K 0.25% 97
2017
Q1
$9.71M Sell
327,652
-41,764
-11% -$1.14M 0.23% 107
2016
Q4
$9.16M Sell
369,416
-133,500
-27% -$3.03M 0.23% 113
2016
Q3
$11.4M Sell
502,916
-3,137
-0.6% -$73.7K 0.29% 100
2016
Q2
$12.1M Sell
506,053
-326,976
-39% -$7.84M 0.32% 87
2016
Q1
$19.8M Sell
833,029
-171,385
-17% -$4.19M 0.49% 59
2015
Q4
$27.9M Sell
1,004,414
-38,992
-4% -$979K 0.67% 44
2015
Q3
$21.6M Sell
1,043,406
-13,035
-1% -$330K 0.53% 63
2015
Q2
$27.1M Buy
1,056,441
+90,966
+9% +$2.3M 0.61% 48
2015
Q1
$24.4M Buy
965,475
+41,378
+4% +$1.01M 0.55% 55
2014
Q4
$22M Sell
924,097
-15,850
-2% -$351K 0.5% 62
2014
Q3
$18.5M Buy
939,947
+459,267
+96% +$9.45M 0.43% 75
2014
Q2
$11.5M Sell
480,680
-22,881
-5% -$552K 0.27% 124
2014
Q1
$13.4M Buy
503,561
+37,390
+8% +$888K 0.32% 103
2013
Q4
$9.41M Buy
+466,171
New +$8.65M 0.22% 138

Other funds holding GMED